|
|
Volumn 4, Issue 4, 2007, Pages 173-
|
|
A polypill for secondary prevention: Time to move from intellectual debate to action
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
BIOEQUIVALENCE;
CARDIOVASCULAR DISEASE;
CARDIOVASCULAR RISK;
COST EFFECTIVENESS ANALYSIS;
DEVELOPING COUNTRY;
DRUG EFFICACY;
DRUG FORMULATION;
DRUG IMPURITY;
DRUG MANUFACTURE;
DRUG QUALITY;
DRUG STABILITY;
EDITORIAL;
HEALTH BEHAVIOR;
HEALTH CARE ACCESS;
HIGH RISK POPULATION;
HUMAN;
LIFESTYLE MODIFICATION;
MORTALITY;
PATIENT ATTITUDE;
PRIMARY PREVENTION;
PRIORITY JOURNAL;
RISK REDUCTION;
SECONDARY PREVENTION;
AGED;
ANTICHOLESTEREMIC AGENTS;
ANTIHYPERTENSIVE AGENTS;
CARDIOVASCULAR DISEASES;
DRUG COMBINATIONS;
FEMALE;
HUMANS;
LIFE EXPECTANCY;
MALE;
MIDDLE AGED;
PATIENT COMPLIANCE;
PLATELET AGGREGATION INHIBITORS;
PROGNOSIS;
RISK ASSESSMENT;
SURVIVAL ANALYSIS;
|
|
EID: 33947631906
PISSN: 17434297
EISSN: 17434300
Source Type: Journal
DOI: 10.1038/ncpcardio0858 Document Type: Editorial |
|
Times cited : (27)
|
|
References (0)
|